Résultats de recherche
Il y a 5 heures · The Phase 3 randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of Dupixent in children aged 1 to 11 years with EoE. Part A enrolled 102 patients and evaluated ...
Il y a 5 heures · Alizé Kaisserian | + 33 6 47 04 12 11 | [email protected] Arnaud Delépine | + 33 6 73 69 36 93 | [email protected] Felix Lauscher | + 1 908 612 7239 | [email protected]
Il y a 5 heures · Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM. Majority of patients in this age group with eosinophilic esophagitis receiving Dupixent achieved histologic remission, with improvements sustained up to one year
